CERA

Tax Appeal 2022

Help shine a light for people with AMD

Did you know that age-related macular degeneration (AMD) is the leading cause of legal blindness in Australia? One in seven Australians over 50 shows early signs of the disease.

AMD research has come a long way in the past decades, helping find new treatments for what was once regarded as an untreatable condition.

But there are still no effective treatments for dry AMD.

Our researchers need your support to help them find the missing piece of the AMD puzzle.

Please, donate today and help shine a light for people with AMD.

Can you remember the frustration you felt when you were one piece short of finishing a jigsaw? Or when the last answer in a crossword didn’t fit?

Since 1997, CERA’s researchers have been trying to piece together the age-related macular degeneration (AMD) puzzle. Every day, every week – of every year.

In those 25 years, we’ve made very significant progress towards both understanding and treating AMD, helping create a much brighter future for people with the condition.

But there’s still a lot of work to be done.

For people like Jim (featured below), who have been diagnosed with dry AMD, there’s still no effective treatment, and the condition can lead to permanent loss of central vision.

Our Macular Research Unit, led by Professor Robyn Guymer AM, is recognised as a world leader in research and clinical management of AMD. In the lab, we have teams investigating the genetic causes of AMD, developing new therapies to treat retinal diseases, and looking at new ways to deliver existing treatments for wet AMD, so that in the future, patients will need fewer injections or be able to take eye drops instead.

Will you help them unlock the secrets of AMD?

Your tax-deductible donation today will help our world-leading researchers find new ways to diagnose, prevent and treat AMD.

Jim’s hope for the future

“Knowing that there is potentially a life-changing operation available for people like me who thought this would never be possible, it’s amazing.”

Jim has advanced dry AMD, which in his case means he can no longer read or see photographs clearly.

He’s also experiencing double vision and knows it’s getting worse.

But he’s keeping a positive attitude: “You can’t stop can you? You’ve just got to get on with it.”

Last year he took part in a clinical trial at CERA investigating a potential new treatment for dry AMD.

25 years of macular research at CERA

CERA’s Macular Research Unit was established a quarter of a century ago by Professor Robyn Guymer AM.

At the time, treatments for the condition were virtually non-existent, and the outcome for most patients would be either a sudden loss of vision or a more gradual, irreversible loss of sight.

In the 25 years that have followed, the team has counted many significant achievements towards both understanding and treating AMD.

Donation

With your support, there’s hope in sight. Your tax-deductible donation helps us continue world-leading vision research to find ways to prevent people from going blind.

I wish to donate

All donations over $2 are tax deductable

As an international leader in vision research, we are deeply committed to research with real-life impact. Together we work to achieve better treatments and faster diagnosis of eye conditions.

Personal details

Thank you for supporting our Tax Appeal 2022

From everyone at CERA, we are truly grateful for your support of research with real-life impact.

Every donation, whatever the size, brings our researchers closer to discoveries that increase the success of AMD treatments and help preserve sight for many Australians.

Thank you for helping us bring hope to people affected by vision loss and blindness.